Open Access is an initiative that aims to make scientific research freely available to all. To date our community has made over 100 million downloads. It’s based on principles of collaboration, unobstructed discovery, and, most importantly, scientific progression. As PhD students, we found it difficult to access the research we needed, so we decided to create a new Open Access publisher that levels the playing field for scientists across the world. How? By making research easy to access, and puts the academic needs of the researchers before the business interests of publishers.
We are a community of more than 103,000 authors and editors from 3,291 institutions spanning 160 countries, including Nobel Prize winners and some of the world’s most-cited researchers. Publishing on IntechOpen allows authors to earn citations and find new collaborators, meaning more people see your work not only from your own field of study, but from other related fields too.
To purchase hard copies of this book, please contact the representative in India:
CBS Publishers & Distributors Pvt. Ltd.
www.cbspd.com
|
customercare@cbspd.com
Department of Internal Medicine, Toho University School of Medicine, Japan
*Address all correspondence to: ueshiba@med.toho-u.ac.jp
1. Introduction
The frequency of adrenal incidentalomas has been reported to range between 0.7% and 4% in abdominal computed tomography [1-5], or from 1.4% to 8.7% in autopsy series [6-8]. The widespread application of high resolution imaging techniques, such as computed tomography, magnetic resonance imaging and ultrasonography, has led to an increasing frequency of discovering adrenal incidentalomas. The majority of these lesions are of cortical origin, include non-functioning adenomas, adenomas associated with pre-clinical Cushing's syndrome, pheochromocytomas, adrenocortical carcinomas, myelolipomas, ganglioneuromas, metastatic tumors and cysts [9-13]. Adrenal incidentalomas are usually asymptomatic, however many of these lesions may secrete weak precursor hormones or active hormones in insufficient amounts to cause clinically apparent disease. There are reports of several cases of adrenal incidentaloma who had no clinical evidence of Cushing’s syndrome and normal basal steroid hormone secretion, but non-suppressible serum cortisol after dexamethasone administration. These cases were regarded as “pre-clinical Cushing’s syndrome” [14-16] and many of them treated by adrenalectomy, which restored a normal cortisol suppression to dexamethasone.
To study the differences between non-functioning adenomas and those associated with pre-clinical Cushing's syndrome, we performed a comprehensive analysis of serum steroid hormone profiles in patients with such adrenocortical tumors using a combination method of high-performance liquid chromatography(HPLC) and radioimmunoassay(RIA) [17].
We studied 22 patients with incidentally discovered adrenal masses. These lesions were seen on abdominal imaging and were diagnosed clinically and/or pathologically. From our adrenal incidentaloma cases, we selected for inclusion only patients with adrenocortical adenomas. Fifteen non-functioning adenoma cases (7 males and 8 females, mean age 59.3±13.7 yr) and seven pre-clinical Cushing's syndrome cases (2 males and 5 females, mean age 54.7±12.4 yr) were studied (Table 1). As the control group, sixteen healthy adults(8 males and 8 females, mean age 51.0±7.4 yr) were used.
Non-functioning
No
Age(yr)
Sex
Side
Size(mm)
BP(mmHg)
Operation
1
71
M
right
25x15
150-80
(+)
2
83
M
right
30x20
160-84
3
74
M
right
30x20
146-86
(+)
4
61
M
left
8x8
130-70
5
49
M
right
22x13
134-78
6
42
M
left
18x12
138-80
7
53
M
left
19x17
142-82
8
87
F
right
32x15
100-80
9
57
F
left
12x12
140-80
10
53
F
right
22x18
104-60
(+)
11
55
F
right
12x9
120-76
12
49
F
right
26x19
124-80
(+)
13
42
F
left
21x18
144-84
14
56
F
left
32x21
128-72
(+)
15
57
F
left
25x29
146-84
Pre-clinical
1
41
M
left
15x10
146-88
Cushing
2
54
M
left
16x11
148-84
3
61
F
right
18x18
130-84
(+)
4
60
F
right
17x13
160-70
(+)
5
59
F
right
17x15
130-82
6
72
F
right
18x12
156-86
(+)
7
36
F
left
22x18
124-80
(+)
Table 1.
Clinical features in cases of non-functioning adenoma and pre-clinical Cushing’s syndrome
2.2. Hormonal measurements
Blood samples were obtained from patients with adrenal masses and normal subjects between 8 and 9 a.m. after an overnight fast. Serum levels of 10 steroid hormones [pregnenolone (Preg), progesterone (P), deoxycorticosterone (DOC), corticosterone (B), 17-hydroxypregnenolone (17-OH-Preg), 17-hydroxyprogesterone (17-OHP), 11-deoxycortisol (S), cortisol (F), dehydroepiandrosterone (DHEA), △4androstenedione (△4A)] were determined by an HPLC/RIA method as previously described [17].
2.3. Statistical analyses
We analyzed product/precursor ratios as indices of the relative activities of adrenal steroidogenic enzymes. Data are shown as mean ± SD. Variables were compared by the Mann-Whitney U test with Bonferroni correction. P values less than 0.05 were considered statistically significant.
2.4. Results
Eleven cases of non-functioning adenomas (Group I) had normal levels in DHEA and △4A compared to normal controls by simultaneous analysis (Fig.1).In 4 cases of non-functioning adenomas (Group II), however, serum levels of DHEA and △4A were significantly decreased compared to normal controls by simultaneous analysis (Fig.2). Other steroid hormone levels were normal in all cases of non-functioning adenomas. Therefore, we divided these patients into two groups based on the relative activities of adrenal steroidogenic enzymes by calculating product/precursor ratios. In pre-clinical Cushing's syndrome, serum levels of DHEA and △4A were significantly decreased compared to normal control values (Fig.3) and these results were similar to values in Group II patients.
17,20-Lyase activities assessed by DHEA/17-OH-Preg and △4A/17-OHP ratios were significantly decreased in Group II of non-functioning adenoma and pre-clinical Cushing's syndrome compared to Group I patients and normal controls (Fig.4). 17-Hydroxylase activities assessed by 17-OH-Preg/Preg and 17-OHP/P ratios (Fig.5), 3β-hydroxysteroid dehydrogenase activities assessed by P/Preg, 17-OHP/17-OH-Preg and △4A/DHEA ratios (Fig.6), 21-hydroxylase activities assessed by DOC/P and S/17-OHP ratios (Fig.7) and 11β-hydroxylase activities assessed by B/DOC and F/S ratios (Fig.8) had the same levels in all cases of non-functioning adenomas and pre-clinical Cushing's syndrome compared to normal control values.
Figure 1.
Serum steroid hormone profiles in non-functioning adrenocortical adenoma Group I
Figure 2.
Serum steroid hormone profiles in non-functioning adrenocortical adenoma Group II
Figure 3.
Serum steroid hormone profiles in pre-clinical Cushing's syndrome
We examined serum steroid hormone profiles of patients with non-functioning adrenocortical adenomas and pre-clinical Cushing's syndrome. We also assessed the steroidogenic enzymatic activities of these patients by analysis of the product/precursor ratios of C21 and C19 steroid hormones in the steroidogenic pathway. Patients with pre-clinical Cushing's syndrome and a subgroup of patients with non-functioning adrenocortical adenomas had distinctly decreased adrenal androgen secretion compared with a suppressed 17,20-lyase activity. The remaining patients with non-functioning adrenocortical adenomas had completely normal adrenal androgen values and 17,20-lyase activity.
Previous reports have shown an exaggerated response of 17-hydroxyprogesterone after ACTH stimulation in some patients with incidentally detected adrenal incidentalomas [18,19]. This response has been explained by existing 21-hydroxylase deficiency which may be a pathogenetic factor in the development of adrenal tumors. Macronodular adrenal hyperplasia is a frequent finding in patients with classic congenital adrenal hyperplasia, however,also about half of the heterozygous carriers in families with congenital adrenal hyperplasia were reported to have uni- or bilateral adrenal nodules on abdominal computed tomography in consecutive 4-mm scans [19].These investigators concluded that mild 21-hydroxylase deficiency is associated with the formation of adrenal incidentaloma. Other investigators have reported that the ACTH-stimulated 17-hydroxyprogesterone levels were abnormally increased in more than 50% of patients with non-hyperfunctioning adrenal adenomas [20]. After unilateral adrenalectomy, this hormonal abnormality disappeared in most patients with adrenal tumors. The ACTH-stimulated 17-hydroxyprogesterone levels significantly correlated with the size of the tumors. These results indicate that tumors themselves may be responsible for the increased ACTH-stimulated 17-hydroxyprogesterone levels in patients with non-hyperfunctioning adrenal adenomas.
In this study, we demonstrated that serum DHEA and △4A levels were significantly decreased in some patients with non-functioning adrenocortical adenomas(Group II) and all those with pre-clinical Cushing's syndrome. 17,20-Lyase activities were significantly decreased in Group II of non-functioning adenoma and pre-clinical Cushing's syndrome compared to Group I patients and normal controls. We found no clinical or pathological differences between Group I patients and Group II patients who had normal adrenal androgen concentrations. We have no explanation as to why there was difference between these groups. Since serum steroid hormone profiles had a similar pattern between some non-functioning adrenocortical adenomas and adenomas of patients with pre-clinical Cushing's syndrome, we suggest that the former may in time progress into pre-clinical and clinical Cushing's syndrome. There are limitations in this study such as small sample size and no tissue investigation. In the future the activity of steroidogenesis enzyme should be measured in the specimens from adrenaltissues.
References
1.BelldegrunA.HussainS.SeltzerS. E.LoughlinK. R.GittesR. F.RichieJ. P.1986Incidentally discovered mass of the adrenal gland.Surg Gynecol Obstet163203208
7.HedelandH.OstbergG.HokfeltB.1968On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes.Acta Med Scand184211214
8.GrangerP.GenestJ.1970Autopsy study of adrenal s in unselected normotensive and hypertensive patients.Can Med Assoc J1033436
10.BencsikZ.SzabolcsI.KovacsZ.FerenczA.VorosA.KaszasI.BorK.GoncziJ.GothM.KovacsL.DohanO.SzilagyiG.1996Low dehydroepiandrosterone sulfate(DHEA-S) level is not a good predictor of hormonal activity in nonselected patients with incidentally detected adrenal tumors.J Clin Endocrinol Metab8117261729
11.Kasperlik-ZatuskaAARostonowskaE.Stowinska-SrzednickaJ.MigdalskaB.JeskeW.MakowskaA.SnochowskaH.1997Incidentally discovered adrenal mass(incidentaloma): investigation and management of 208 patients.Clin Endocrinol462937
12.BarzonL.ScaroniC.SoninoN.FalloF.PaolettaA.BoscaroM.1999Risk factors and long-term follow-up of adrenal incidentalomas.J Clin Endocrinol Metab84520526
13.ManteroF.TerzoloM.ArnaldiG.OsellaG.MasiniA. M.AliA.GiovagnettiM.OpocherG.AngeliA.2000A survey on adrenal incidentaloma in Italy.J Clin Endocrinol Metab85637644
14.BognerU.EggensU.HensenJ.OelkersW.1986Incidentally discovered ACTH-dependent adrenal adenoma presenting as "pre-Cushing’s syndrome."Acta Endocrinol1118992
15.RosenH. N.SwartzS. L.1992Subtle glucocorticoid excess in patients with adrenal incidentaloma. Am J Med92213216
16.RenickeM.NiekeJ.KrestinG. P.SaegerW.AllolioB.WinkelmannW.1992Preclinical Cushing’s syndrome in adrenal "incidentaloma:" comparison with adrenal Cushing’s syndrome.J Clin Endocrinol Metab75826832
17.UeshibaH.SegawaM.HayashiT.MiyachiY.IrieM.1991Serum profiles of steroid hormones in patients with Cushing’s syndrome determined by a new HPLC/RIA method. Clin Chem3713291333
18.SeppelT.SchlagheckeR.1994Augmented 17-alpha-hydroxyprogesterone response to ACTH stimulation as evidence of decreased 21-hydroxylase activity in patients with incidentally discovered adrenal’incidentalomas.’Clin Endo41445451
19.JareschS.KornelyE.KleyH. K.SchlagheckeR.1992Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia.J Clin Endocrinol Metab74685689
20.TothM.RaczK.AdleffV.FutoL.JakabC.KarlingerK.KissR.GlazE.2000Comparative analysis of plasma 17-hydroxyprogesterone and cortisol responses to ACTH in patients with various adrenal tumors before and after unilateral adrenalectomy.J Endocrinol Invest23287294